Castle Biosciences Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About CSTL
Castle Biosciences, Inc. is a diagnostics company improving health through tests that guide patient care. The Company’s portfolio consists of tests for skin cancers, Barrett’s esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. Its products include DecisionDx-Melanoma, DecisionDx-SCC, MyPath Melanoma, TissueCypher, IDgenetix, and DecisionDx-UM. DecisionDx-Melanoma is its risk stratification gene expression profile (GEP) test that predicts the likelihood of positive sentinel lymph node and the risk of metastasis, or recurrence, for patients diagnosed with invasive cutaneous melanoma (CM). DecisionDx-SCC is its GEP test for use in patients with cutaneous squamous cell carcinoma (SCC).
Find out what a historical investment in Castle Biosciences Inc would be worth today using our CSTL stock calculator.
$476.39M
-
0.00%
318.5K
$16.48
$15.89
$16.34
$35.84
$15.70
Ready to start your investing journey with Stake?
Open an accountCSTL FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CSTL
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CSTL
on Stake
Buy CSTL from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of CSTL from only US$10 with fractional shares
